Skip to main content

Table 5 Association between invasive therapy and 28-day-case fatality by age category

From: Predictors of non-invasive therapy and 28-day-case fatality in elderly compared to younger patients with acute myocardial infarction: an observational study from the MONICA/KORA Myocardial Infarction Registry

 

Age category

25–64 years

65–74 years

75–84 years

OR [95 % CI]

p Value

OR [95 % CI]

p Value

OR [95 % CI]

p Value

Model 1a

0.19 [0.10–0.36]

<0.0001

0.28 [0.17–0.46]

<0.0001

0.43 [0.30–0.62]

<0.0001

Model 2b

0.35 [0.15–0.84]

0.02

0.45 [0.22–0.92]

0.03

0.39 [0.24–0.63]

<0.0001

  1. a Model 1 adjusted for sex for the total sample (n = 3475)
  2. b Model 2 adjusted for sex, body mass index ≥30 kg/m2, type of AMI, renal dysfunction, prior stroke, prior MI, history of diabetes, hypertension, hyperlipidemia, angina pectoris and chronic obstructive pulmonary disease, any in-hospital complication (without cardiac arrest), pre-hospital time, left ventricular ejection fraction, peak serum creatine phosphokinase (CPK) level, and in-hospital medication: dual antiplatelet therapy, beta-blockers, statins, and angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers. As 23 patients had no data on peak serum CPK level, the total sample size was 3452
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us